大健康国际品牌怎么样 申请店铺
大健康国际集团控股有限公司（「大健康国际」或「公司」，股份代号：［2211］）是中国东北地区领先的医药零售商及分销商之一。公司拥有中国东北地区较大的医药零售连锁网络并为中国东北地区较大的民营医药分销商。截至最后实际可行日期，公司在中国东北地区拥有953家零售药店，并在香港有四家零售药店，全部均为自营药店。公司拥有约6,500名分销客户。公司拥有较高的净利润率，得益于侧重品牌高毛利产品的产品组合、独特的直供模式、集中采购平台和低运营成本。公司通过金天学院为员工和客户提供培训课程，亦具备强大的收购与整合执行力，将产品组合、先进的业务模式及成熟的营运程序运用至被收购业务。公司已形成独特的商业模式和核心竞争优势，并致力在药品零售及分销的专业基础上，充实更多健康类产品进入销售管道，推行大健康行业理念。
Dahealth International Group Holdings Limited ("dahealth international" or "company", stock code: [2211]) is one of the leading pharmaceutical retailers and distributors in Northeast China. The company has a large pharmaceutical retail chain network in Northeast China and is a large private pharmaceutical distributor in Northeast China. As of the last practical date, the company has 953 retail pharmacies in Northeast China and four retail pharmacies in Hong Kong, all of which are self-supporting. The company has about 6500 distribution customers. The company has a high net profit margin, thanks to the product mix focusing on high brand gross profit products, unique direct supply mode, centralized procurement platform and low operating cost. The company provides training courses for employees and customers through Jintian college, and has strong executive power of acquisition and integration, applying product portfolio, advanced business model and mature operation procedures to the acquired business. The company has formed a unique business model and core competitive advantage, and is committed to enriching more health products into the sales channels and promoting the concept of big health industry on the basis of drug retail and distribution.
浙公网安备 33011802001999号
